Verastem Inc (VSTM) reports significant revenue growth and FDA approval, but faces hurdles with NCCN guidelines and financial losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results